Mutant Prevention Concentrations of ABT-492, Levofloxacin, Moxifloxacin, and Gatifloxacin against Three Common Respiratory Pathogens

The purpose of this study was to compare the mutant prevention concentration (MPC) of ABT-492 to those of levofloxacin, moxifloxacin, and gatifloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The fluoroquinolones had comparable mutation selection windows,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hermsen, Elizabeth D., Hovde, Laurie B., Konstantinides, George N., Rotschafer, John C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2005
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1068586/
https://ncbi.nlm.nih.gov/pubmed/15793158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.4.1633-1635.2005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados